文献速递前列腺增生与排尿功能障碍小儿泌尿与泌尿修复

尿神经生长因子可预测儿童膀胱过度活动症的治疗效果

Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
PubMed 文献 · Urology · 2017-02-01

本研究纳入35例膀胱过度活动症(OAB)患儿和11例对照儿童,检测尿神经生长因子/肌酐(NGF/Cr)水平。OAB患儿尿NGF/Cr显著高于对照组(0.65 ± 0.82 vs 0.11 ± 0.09,P = .0007);35例中26例(74%)症状改善,9例为难治性OAB,难治组尿NGF/Cr显著高于改善组(1.28 ± 1.34 vs 0.44 ± 0.39,P = .027)。尿NGF/Cr可能作为儿童OAB的生物标志物及疗效预测指标。

要点

  • OAB患儿尿NGF/Cr显著高于对照组(0.65 ± 0.82 vs 0.11 ± 0.09,P = .0007)。
  • 35例OAB患儿中26例(74%)症状改善,9例为难治性OAB。
  • 难治组尿NGF/Cr显著高于改善组(1.28 ± 1.34 vs 0.44 ± 0.39,P = .027)。

核心结论

  • 尿NGF/Cr在OAB患儿中显著高于对照组,在难治组中显著高于改善组,可能作为儿童OAB的生物标志物及疗效预测指标。

研究设计与样本

  • 研究纳入35例OAB患儿(27例男孩、8例女孩)和11例无OAB或其他泌尿系统症状的对照儿童(6例男孩、5例女孩)。
  • 采用酶联免疫吸附试验测定尿NGF水平,并以尿肌酐浓度校正得到尿NGF/Cr水平。
  • 难治性OAB定义为经过至少3个月排尿训练和抗胆碱能药物治疗后OAB症状改善甚微。

主要发现

  • OAB患儿尿NGF/Cr显著高于对照组(0.65 ± 0.82 vs 0.11 ± 0.09,P = .0007)。
  • 35例OAB患儿中26例(74%)观察到OAB症状改善,其余9例为难治性OAB(难治组)。
  • 难治组尿NGF/Cr显著高于改善组(1.28 ± 1.34 vs 0.44 ± 0.39,P = .027)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess urinary nerve growth factor (NGF) in children with overactive bladder (OAB) and to investigate the relationship between urinary NGF/creatinine (Cr) levels and OAB. PATIENTS AND METHODS: Thirty-five children (27 boys and 8 girls) with OAB and 11 children (6 boys and 5 girls) without OAB or any other urinary symptoms, who served as controls, were included in this study. Urinary NGF levels were measured using enzyme-linked immunosorbent assay. The total urinary NGF levels were adjusted with the concentration of urinary creatinine (NGF/Cr level). Refractory OAB was defined as little improvement in OAB symptoms despite at least 3 months of urotherapy and anticholinergic agent treatment. Urinary NGF/Cr was compared between the children with OAB and the controls. The relationship between urinary NGF/Cr and treatment outcomes was also evaluated. RESULTS: Urinary NGF/Cr was significantly higher in the children with OAB when compared with those in the control group (0.65 ± 0.82 vs 0.11 ± 0.09, P = .0007). Improvement of OAB symptoms was observed in 26 out of 35 children (74%). The remaining 9 children showed refractory OAB symptoms (the refractory group). Urinary NGF/Cr was significantly higher in the refractory group than in the improved group (1.28 ± 1.34 vs 0.44 ± 0.39, P = .027). CONCLUSION: Urinary NGF/Cr was significantly higher in the children with OAB than in the controls, and was significantly higher in the refractory group than in the improved group. Urinary NGF/Cr could not only be a potential biomarker for children with OAB, but also a predictor of therapeutic efficacy in children with OAB.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Fukui S, Aoki K, Morizawa Y, et al. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder. Urology. 2017. PMID: 28161379. doi:10.1016/j.urology.2017.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。